Evonik Expanding MMAT Plant In Mobile, Alabama, To Meet Customer Demand
Responding to the strength of the markets it serves, Evonik Corporation said today it will expand its specialty methacrylate monomer facility in Mobile, Ala.
The methyl methacrylate transesterification (MMAT) plant, within Evonik’s Performance Polymers Business Unit and Acrylic Monomers Business Line, will begin a multi-million dollar expansion immediately. The project is expected to be completed by the end of 2014.
“This action reflects the strength of the markets supplied by the MMAT plant and a continued confidence in the ability of Evonik’s Mobile site to deliver impressive results to Evonik’s Performance Polymers business,” said Helio Takahashi, president, Evonik Performance Polymers North America.
The expansion will significantly increase the MMAT plant capacity and will require an additional staff of up to six positions.
The monomers produced at the MMAT plant are used in a variety of applications from paint coatings to personal care super absorbers to viscosity modifiers.
For competitive reasons, Evonik does not provide details about the scope of the expansion nor the amount of the investment.
With approximately 750 workers, Evonik Corporation's Mobile site is one of the area's largest employers. It manufactures a wide range of products that create the essentials necessary to enjoy a better standard of living today and tomorrow.
For additional information about Evonik in North America, please visit our website: www.evonik.com/north-america. Please visit us on Facebook at www.facebook.com/EvonikNorthAmerica. Follow us on Twitter at http://twitter.com/EvonikN_America.
Evonik Corporation has begun a multi-million dollar expansion of its specialty methacrylate monomer facility in Mobile, which is expected to be completed later this year.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion (excluding Real Estate in both cases).
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.